Financings
Zentek Announces That Its Brokered LIFE Offering Is Oversubscribed and Fully Allocated
Zentek Secures Liquidity with Oversubscribed Offering Amid Nasdaq Compliance Pressure

Executive Summary
- Financing Completion: Zentek Ltd. announced on May 19, 2026, that its previously brokered private placement (announced May 14) is oversubscribed and fully allocated.
- Capital Raised: Gross proceeds of up to C$15,000,000 through the sale of 15,000,000 units at C$1.00 per unit. An option exists for an additional C$3,000,000 (Red Cloud Securities Inc.).
- Use of Proceeds: Funds are earmarked for the Albany Graphite Project development (including a new Preliminary Economic Assessment by Micon International), commercialization of ZenGUARD™, and general working capital.
- Warrant Terms: Each unit includes one warrant to purchase a common share at C$1.50, exercisable within 36 months.
- Management Commentary: CEO Mohammed Jiwan cited "institutional confidence" in the company's value-creation path across Albany Graphite, ZenGUARD™, and Triera as drivers for the oversubscription.
Material Impact
- Liquidity & Dilution: The C$15M raise provides essential runway to execute the 24-month plan but introduces significant dilution (approx. 15M new shares). Given the recent trading price of ~$0.93-$1.36, the $1.00 offering price represents a slight premium over the immediate pre-offering lows but discounts from the May 14 peak ($1.36), indicating market skepticism regarding valuation at that level.
- Nasdaq Compliance: The offering price of C$1.00 aligns with the Nasdaq minimum bid price requirement (deadline August 24, 2026). While this provides a floor for trading psychology, it does not guarantee compliance if market sentiment shifts back below $1.00 post-closing.
- Validation: Oversubscription is a positive signal of demand, countering the negative sentiment seen in the price drop from $1.36 to $0.93 between May 14 and May 15. However, financing announcements are standard for pre-revenue juniors; without a strategic investor (e.g., Sprott, Lundin), this does not fundamentally alter the risk profile of the assets.
- Catalyst Timing: The closing is expected by May 27, 2026. This provides immediate cash but pushes the PEA completion to Summer 2026 as planned.
ZEN · Price
Company Overview
- Flagship Project: Albany Graphite Project (Ontario). Focuses on producing 5N+ nuclear-grade graphite (99.9992% purity) with low boron (<3 ppm).
- Secondary Assets: ZenGUARD™ Enhanced Air Filters (graphene-based filtration, commercialized via ISC pathway) and Triera Biosciences (aptamer technology for infectious disease).
- Development Stage: Albany is in the PEA/Pre-Feasibility stage. ZenGUARD is in early commercialization with government procurement agreements. Triera is advancing R&D contracts.
More from Zentek Ltd.
Jul 07, 2026 · 09:19